SIRT1 could also upregulate matrix metalloproteinase-2 (MMP-2) level in BC cell lines by its deacetylation activity, exhibiting a direct correlation with advanced TNM stage, higher rates of lymph node metastasis (LNM) and poor survival of patients [47]. Here, SIRT1 is linked to metastatic malignant neoplasm in the lymph nodes.